Quick dip into Tsuta for amazing ramen before our flights out of #WCLC23 . Dean Fennell FRCP Changi Airport

Dr Pasi Jänne Dana Farber's EGFR-Mutant Lung Cancer Center presenting the results of FLAURA2 trial, Osimertinib in combination with Carbo-Pemtrexed in pts with advanced EGFR + NSCLC. Improving of PFS. Increased toxicity, specially hematological. Questions open! IASLC EGFR Resisters #WCLC2023

The effort to complete and conduct this trial during the #COVID19 pandemic needs to be highlighted 👏
AND should serve as an example to all on how to obtain patient input for what is a meaningful benefit to them

#WCLC23

polarispharma.com/2022/09/21/202…

V interesting signal for pembrolizumab + lenvatinib Excellent discussion by Dr Ceresoli

....'customised coffee' pre- mesothelioma sessions this afternoon. Looking forward to it !

The first patient has been consented into the NERO #ClinicalTrial , officially commencing recruitment to this exciting randomised study.
NERO looks at whether a targeted #cancer drug could improve survival for people with #mesothelioma .
Find out more bit.ly/3zAv54m

Skyscraper 2 falls. Probably not that surprising given how hard it is to get a positive #SCLC study. #LCSM Genentech: Press Releases | Tuesday, Mar 29, 2022 gene.com/media/press-re…

Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): ... sciencedirect.com/science/articl…

New #JITC review: Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy ow.ly/21Ag50G9DSb Dean Fennell FRCP

Join us on 14 Oct as we hear from Dean Fennell FRCP, Dr Julia Morris CRUK Manchester Institute & Della Ogunleye NHS South West London about their experiences of being black in #cancerresearch

This free webinar will be chaired by Richard Sullivan & has been organised with BlackinCancer

👉 bit.ly/3tJqycm

Really pleased to see our review on Mesothelioma out in NEJM this week @AlrifaiDoraid Dean Fennell FRCP. A great update for all on this disease so in need of further research and innovation. DOI: 10.1056/NEJMra1912719

Exciting news for #mesothelioma patients. A new era in the management of this disease begins. Eager to see details.
news.bms.com/press-release/…

Welcome news for #mesothelioma . Waiting for specifics. Hopefully this trial wont be a fubar.

news.bms.com/press-release/…

Combine art & outdoor adventure and you get Brisbane, where creative spaces, music and hip restaurants meet beautiful riverside gardens and man-made beaches. #Brisbane is #Australia 's 3rd largest city & the host city for iMig 2020.
Learn more: imig2020.org/r74o
#iMig2020

Mutations in the Hippo signalling pathway make cells susceptible to a type of cell death called ferroptosis. A terrific N&V by Dean Fennell FRCP explains the implications for the treatment of a cancer termed mesothelioma go.nature.com/2yfYaCx

The “Nivo-lution in mesothelioma” is here. It was fun to write this editorial with ⁦@MGZauderer⁩ for ⁦Clinical Cancer Research⁩ clincancerres.aacrjournals.org/content/early/…